Bulk Manufacturer of Controlled Substances Application: Noramco, Inc., 41055-41056 [2017-18315]

Download as PDF 41055 Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on January 18, 2017, Stepan Company, Natural Products Dept., 100 W. Hunter Avenue, Maywood, New Jersey 07607 applied to be registered as an importer of coca leaves (9040), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance in bulk for the manufacture of controlled substance for distribution to its customers. Dated: August 21, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–18313 Filed 8–28–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Cambrex Charles City ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before September 28, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before September 28, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and DATES: (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and request for hearing on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007). SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Office of Diversion Control (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on June 12, 2017, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance Drug code 4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... Phenylacetone ................................................................................................................................................................. Coca Leaves .................................................................................................................................................................... Opium, raw ...................................................................................................................................................................... Poppy Straw Concentrate ............................................................................................................................................... The company plans to import the listed controlled substances for internal use, and to manufacture bulk intermediates for sale to its customers. Dated: August 21, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–18314 Filed 8–28–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE sradovich on DSK3GMQ082PROD with NOTICES Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Noramco, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and DATES: VerDate Sep<11>2014 18:45 Aug 28, 2017 Jkt 241001 applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before October 30, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 8333 8501 9040 9600 9670 Schedule II II II II II substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on July 6, 2017, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801–4417 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Marihuana ..................... Tetrahydrocannabinols Codeine-N-oxide ........... Dihydromorphine .......... Hydromorphinol ............ E:\FR\FM\29AUN1.SGM 29AUN1 Drug code 7360 7370 9053 9145 9301 Schedule I I I I I 41056 Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices Controlled substance Morphine-N-oxide ......... Amphetamine ............... Methylphenidate ........... Nabilone ....................... Phenylacetone .............. Codeine ........................ Dihydrocodeine ............. Oxycodone ................... Hydromorphone ............ Hydrocodone ................ Morphine ....................... Oripavine ...................... Thebaine ....................... Opium extracts ............. Opium fluid extract ....... Opium tincture .............. Opium, powdered ......... Opium, granulated ........ Oxymorphone ............... Noroxymorphone .......... Tapentadol .................... Drug code Schedule 9307 1100 1724 7379 8501 9050 9120 9143 9150 9193 9300 9330 9333 9610 9620 9630 9639 9640 9652 9668 9780 I II II II II II II II II II II II II II II II II II II II II The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. In reference to drug code 7360, the company plans to manufacture a synthetic version of cannabidiol in bulk for sale to its customers, who are final dosage form manufacturers. No other activity for this drug code is authorized for this registration. Dated: August 21, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–18315 Filed 8–28–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1125–0005] Agency Information Collection Activities; Proposed Collection; Comments Requested; Request To Be Included on the List of Pro Bono Legal Service Providers for Individuals in Immigration Proceedings (Form EOIR– 56) Executive Office for Immigration Review, Department of Justice. ACTION: 30-day Notice. sradovich on DSK3GMQ082PROD with NOTICES AGENCY: SUMMARY: The Department of Justice (DOJ), Executive Office for Immigration Review (EOIR), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register on June 26, 2017, allowing for a 60-day comment period. VerDate Sep<11>2014 18:45 Aug 28, 2017 Jkt 241001 Comments are encouraged and will be accepted for additional days until September 28, 2017. FOR FURTHER INFORMATION CONTACT: If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Jean King, General Counsel, USDOJ–EOIR–OGC, Suite 2600, 5107 Leesburg Pike, Falls Church, Virginia, 20530; telephone: (703) 305–0470. Written comments and/or suggestions can also be sent to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503 or sent to OIRA_submissions@omb.eop.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and/or —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this information collection: 1 Type of Information Collection: Revision of a currently approved collection. 2 The Title of the Form/Collection: Request to be Included on the List of Pro Bono Legal Service Providers for Individuals in Immigration Proceedings. 3 The agency form number: EOIR–56 (OMB #1125–0015). 4 Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Legal service providers seeking to be included on the List of Pro Bono Legal Service Providers (‘‘List’’), a DATES: PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 list of persons who have indicated their availability to represent aliens on a pro bono basis. Abstract: EOIR seeks to replace the current paper version of the EOIR Forms-56, with an electronic system to make an initial application and apply for continued participation in the List. Form EOIR–56 will be mandatory, and is intended to elicit, in a uniform manner, all of the required information for EOIR to determine whether an applicant meets the eligibility requirements for inclusion on the List. 5 An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 161 respondents will complete each form within approximately 30 minutes. 6 An estimate of the total public burden (in hours) associated with the collection: 80.5 annual burden hours. If additional information is required contact: Jake Bishop-Green, Acting Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., 3E.405B, Washington, DC 20530. Dated: August 24, 2017. Jake Bishop-Green, Acting Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2017–18287 Filed 8–28–17; 8:45 am] BILLING CODE 4410–30–P DEPARTMENT OF JUSTICE [OMB Number 1121–0220] Agency Information Collection Activities; Proposed New e-Collection; Bureau of Justice Assistance Application Form: Public Safety Officers’ Benefits (PSOB) Program Applications Package Bureau of Justice Assistance, Department of Justice. ACTION: 30-day notice. AGENCY: SUMMARY: The Department of Justice, Office of Justice Programs, Bureau of Justice Assistance, will be submitting the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 30 days until September 28, 2017. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the E:\FR\FM\29AUN1.SGM 29AUN1

Agencies

[Federal Register Volume 82, Number 166 (Tuesday, August 29, 2017)]
[Notices]
[Pages 41055-41056]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18315]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Noramco, 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before October 30, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on July 
6, 2017, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 
19801-4417 applied to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
Codeine-N-oxide........................     9053  I
Dihydromorphine........................     9145  I
Hydromorphinol.........................     9301  I

[[Page 41056]]

 
Morphine-N-oxide.......................     9307  I
Amphetamine............................     1100  II
Methylphenidate........................     1724  II
Nabilone...............................     7379  II
Phenylacetone..........................     8501  II
Codeine................................     9050  II
Dihydrocodeine.........................     9120  II
Oxycodone..............................     9143  II
Hydromorphone..........................     9150  II
Hydrocodone............................     9193  II
Morphine...............................     9300  II
Oripavine..............................     9330  II
Thebaine...............................     9333  II
Opium extracts.........................     9610  II
Opium fluid extract....................     9620  II
Opium tincture.........................     9630  II
Opium, powdered........................     9639  II
Opium, granulated......................     9640  II
Oxymorphone............................     9652  II
Noroxymorphone.........................     9668  II
Tapentadol.............................     9780  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers. In reference to 
drug code 7360, the company plans to manufacture a synthetic version of 
cannabidiol in bulk for sale to its customers, who are final dosage 
form manufacturers. No other activity for this drug code is authorized 
for this registration.

    Dated: August 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-18315 Filed 8-28-17; 8:45 am]
 BILLING CODE 4410-09-P